Miaoxian Dong

Prof. Miaoxian Dong


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in Life Sciences
Verified
Journal Article
Closed access
XWXiao-Li Wang
Xiao-Li Wang
GXGui-Hua Xing
Gui-Hua Xing
BHBo Hong
Bo Hong
XLXiao-Ming Li
Xiao-Ming Li
YZYu Zou
Yu Zou
MDMiaoxian Dong
Miaoxian Dong

18 December 2013 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
YZYanyan Zhou
Yanyan Zhou
NXNing Xie
Ning Xie
LLLibo Li
Libo Li
YZYu Zou
Yu Zou
XZXiaojie Zhang
Xiaojie Zhang
MDMiaoxian Dong
Miaoxian Dong
Increasing evidence demonstrates that β-amyloid (Aβ) elicits oxidative stress, which contributes to the pathogenesis and disease progression of Alzhei

1 January 2015 in Neuroscience
Verified
Journal Article
Closed access
HDH. Dong
H. Dong
RLR. Li
R. Li
CYC. Yu
C. Yu
TXT. Xu
T. Xu
XZX. Zhang
X. Zhang
MDMiaoxian Dong
Miaoxian Dong

1 April 2018 in Laboratory Investigation
Verified
Journal Article
Open access
PDF file
TXTianjiao Xu
Tianjiao Xu
CNChengu Niu
Chengu Niu
XZXiaojie Zhang
Xiaojie Zhang
MDMiaoxian Dong
Miaoxian Dong
Recently, the significantly higher incidence of Alzheimer’s disease (AD) in women than in men has been attributed to the loss of neuroprotective estrogen after menopause. Does phytoestrogen have the ability to protect against amyloid-β (Aβ) toxicity? The aim of this study was to evaluate hypothesis that β-ecdysterone (β-Ecd) protects SH-SY5Y cells from Aβ-induced apoptosis by separate signaling pathways involving protein kinase B (Akt) and c-Jun N-terminal kinase (JNK). Here, we demonstrate that phytoestrogen β-Ecd inhibits Aβ-triggered mitochondrial apoptotic pathway, as indicated by Bcl-2/Bax ratio elevation, cytochrome c (cyt c) release reduction, and caspase-9 inactivation. Interestingly, β-Ecd upregulates Bcl-2 expression in SH-SY5Y cells under both basal and Aβ-challenged conditions, but downregulates Bax expression only in Aβ-challenged conditions. Subsequently, Akt-dependent NF-κB activation is required for Bcl-2 upregulation, but not Bax downregulation, in response to β-Ecd, which was validated by the use of LY294002 and Bay11-7082. Notably, β-Ecd attenuates the Aβ-evoked reactive oxygen species (ROS) production, apoptosis signal-regulating kinase 1 (ASK1) phosphorylation and JNK activation without altering the basal ASK1 phosphorylation and JNK activation. ROS-scavenging by diphenyleneiodonium (DPI) abrogated the ability of β-Ecd to alter the activation of ASK1. Simultaneously, inhibition of JNK by SP600125 abolished β-Ecd-induced Bax downregulation in Aβ-challenged SH-SY5Y cells, whereas LY294002 failed to do so. Consequently, β-Ecd possesses neuroprotection by different and complementary pathways, which together promote a Bcl-2/Bax ratio. These data support our hypothesis and suggest that β-Ecd is a promising candidate for the treatment of AD.

8 November 2017 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
QLQiang Li
Qiang Li
CNChengu Niu
Chengu Niu
XZXiaojie Zhang
Xiaojie Zhang
MDMiaoxian Dong
Miaoxian Dong

12 April 2021 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
YNYingcai Niu
Yingcai Niu
JZJing Zhang
Jing Zhang
MDMiaoxian Dong
Miaoxian Dong